Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Irwin Naturals Inc (OP: IWINF )

2.140 -0.030 (-1.38%)
Streaming Delayed Price Updated: 9:30 AM EDT, Mar 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Irwin Naturals Inc

< Previous 1 2 Next >
Psyched: Australia As Psychedelics Hub, Advanced Scans Of Brain On DMT, New PAC For Congressional Influence, 9 States Advancing Bills & More
Australia: Enveric, FSD Pharma, Psyence & Others Advance Businesses 
Via Benzinga
Irwin Naturals Cannabis Products Launch Nationwide In Canada
Irwin Naturals Inc. (OTCQB: IWINF) (CSE:IWIN) (FRA:97X) announced the release of Irwin Naturals Cannabis’ new CBD 25mg Softgels in Canada, available nationwide through the Starseed Medicinal Medical... 
Via Benzinga
Irwin Naturals Acquires Ketamine Media
Irwin Naturals Inc. (OTCQB: IWINF) (CSE:IWIN) (FRA: 97X) acquired Keta Media, LLC, dba Ketamine Media. 
Via Benzinga
Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More
Psychedelics Reform Update: 22 States Where Proposals Are Being Discussed & Local Moves Considered 
Via Benzinga
Major Ketamine Clinics Chain Decides Not To Pursue Acquisition Deal
Irwin Naturals Inc. 
Via Benzinga
In-Clinic Ketamine Businesses Are Shutting Down All Across The US, A Rising Trend?
Closely following the announcement of what's to become of the new regulations for telehealth, including ketamine therapy, several of in-clinic treatment centers have announced they are closing their... 
Via Benzinga
Here Are The Year's Highest Priced Psychedelics Stocks In US Markets
After everything that's happened in the last several years, we believe it's safe to say that the psychedelic renaissance is a reality, one that Benzinga has consistently reported on.   
Via Benzinga
Braxia Scientific's Q3 2023 Finances, Update On Upcoming Acquisition With Irwin Naturals
Research and telemedicine company Braxia Scientific Corp. (OTC: BRAXF) has filed its financial statements for the third quarter ended Dec. 
Via Benzinga
Psyched: Hawaii And Minnesota's Bills, Studying 2C-B Vs. Psilocybin, Filament CEO, Plus Brock Pierce And Jeremy Gardner Discuss The Industry's Future And More
Two Bills Approved By Hawaii Senators With Governor's Endorsement Hawaii Senate Ways and Means Committee approved a pair of bills aiming to promote and investigate the therapeutic potential of MDMA and... 
Via Benzinga
Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More
Psychedelics States Reform: Utah, Iowa, Missouri and Oklahoma’s New Bills; Hawaii, Arizona and Washington's Green Lights, New Hampshire's Setback Earlier this week, three bills were introduced and... 
Via Benzinga
Irwin Naturals Acquires Ketamine Clinic In Kentucky Adding $3M In Projected EBITDA
Irwin Naturals Inc. (OTCQB: IWINF) (CSE:IWIN) (FRA:97X) has successfully completed the acquisition of Serenity Health, LLC, a ketamine clinic in Louisville, KY. The agreement with Serenity was... 
Via Benzinga
Psyched: Australia Legalizes Psychedelics Therapy, BC's Decrim, State Bills, Millions For Trials & Clinics
Australian Health Authority To Allow Psilocybin And MDMA-Assisted Therapy For Depression, PTSD Beginning on July 1, 2023, medicines containing psilocybin and MDMA can be prescribed by specifically... 
Via Benzinga
'Sea Change': Irwin Naturals, Numinus And Field Trip Discuss Psychedelics At Cantor Webinar
Cantor Fitzgerald's Pablo Zuanic hosted a virtual panel discussion about the psychedelics industry with three ketamine therapy providers: Irwin Naturals (OTCMKTS: IWINF)’ CEO Klee Irwin, Field Trip H&W... 
Via Benzinga
Irwin Naturals Secures $40M To Accelerate Expansion Of Its Psychedelic Mental Health Clinics
Irwin Naturals Inc. 
Via Benzinga
Irwin Naturals Signs LOI To Acquire Braxia Scientific Expanding Its Network Of Mental Health Clinics
Irwin Naturals Inc. 
Via Benzinga
Irwin Naturals TCH Products To Hit The Shelves Of ~2700 Dispensaries In Oklahoma Via Gold Rush
Irwin Naturals Inc. (OTCQB: IWINF) (CSE:IWIN) (FRA:97X) entered into a licensing agreement with a partner in Oklahoma to produce and distribute Irwin Naturals THC products. 
Via Benzinga
Irwin Naturals, Numinus, Field Trip: Sector Analyst Compares Footprints, Cash, Organic Growth
The Analyst 
Via Benzinga
6 Psychedelics Companies Take Action: Here Are The Latest, Major Announcements
Second week of 2023, and business is up and running. Let’s take a look at the announcements shared by some of the companies in the psychedelics space. 
Via Benzinga
Irwin Naturals To Enter Oregon Cannabis Market Via Hyphae Wellness
Irwin Naturals Inc. (OTCQB: IWINF) (CSE:IWIN) (FRA: 97X) signed a licensing agreement with JV 805 LLC dba Hyphae Wellness, to manufacture, sublicense and distribute Irwin Naturals THC products... 
Via Benzinga
Psyched: Psychedelic Therapy In The Workplace, UCL's Brain Imaging Study, COMPASS Trials And More
Psychedelic Therapy Now Available As Workplace Benefit, Free Month For Laid-Off Tech Workers 
Via Benzinga
Mental Health Clinic Poised To Become Leader In A Projected $50B Industry, Analyst Says
Irwin Naturals Inc. (OTCQB: IWINF) reported Tuesday a 7% year-over-year decline in revenue to $22 million for the third quarter of 2022. 
Via Benzinga
Irwin Naturals Completes The Acquisition Of Three Mental Health Clinics
Irwin Naturals Inc. (OTCQB: IWINF) (CSE:IWIN) (FRA: 97X) completed the acquisition of the assets of Clare Clinic, Inc., d/b/a Florida Mind Health Center. 
Via Benzinga
Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal's Decrim Project
Psychedelic Research & Fed Funding By The National Institute Of Mental Health The National Institute of Mental Health (NIMH) named the types of psychedelics studies to which it would grant funds and... 
Via Benzinga
Irwin Naturals Q3 Revenue Declines 7% YoY, What About Adjusted EBITDA?
Irwin Naturals Inc. (OTCQB: IWINF) (CSE:IWIN) (FRA:97X) revenue in the Q3 2022 decreased 7% to $22 million, compared to $23.7 million in the Q3 2021. Q3 2022 Financial Highlights 
Via Benzinga
Irwin Naturals To Acquire Serenity Health
Irwin Naturals Inc. (OTCQB: IWINF) (CSE:IWIN) (FRA:97X) signed a binding, arms-length, agreement to acquire Serenity Health, LLC in Louisville, Kentucky, on November 25, 2022. 
Via Benzinga
Irwin Naturals THC Products To Be Available In Mississippi Cannabis Dispensaries
Irwin Naturals Inc. (OTCQB: IWINF) (CSE:IWIN) (FRA: 97X) entered into a licensing and supply agreement with Mockingbird Cannabis, LLC to produce and distribute Irwin Naturals THC products in... 
Via Benzinga
Florida's Growing Psychedelic Treatment Options: Healthcare Company Expands Network Of Clinics
Senior health brand Irwin Naturals Inc. 
Via Benzinga
Ketamine Therapy: Revitalist's New Financing Option, Irwin Naturals Expands Chain Of Clinics
Revitalist Increases Patient Access By Financing Costs With M-Lend Financial 
Via Benzinga
Psyched: CA's Psychedelic-Assisted Treatments, Ketamine Therapy, Near-Death Experience And More
Alberta Becomes The First Canadian Province To Regulate Psychedelics-Assisted Therapy 
Via Benzinga
Ketamine Therapy At Your Doorstep, Growing Number Of Clinics Offer This Treatment Option
Being the sole psychedelic legally available as medicine, ketamine-assisted therapy services are expanding at a rapid pace across the U.S.  
Via Benzinga
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.